Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Coordenação de Aperfeiçoamento de Pessoal de Nível Superior. | OTHER_GOV |
| Fundação de Amparo à Pesquisa do estado de Minas Gerais | OTHER |
| United States Agency for International Development (USAID) | FED |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Nut consumption is associated with reduced risk of Type 2 diabetes. The aim of this study was to assess the effects of peanut (whole or peanut butter) to breakfast meals on glycemic, insulinemic and selected gut hormone responses, appetite, and food intake over two consecutive meals in obese women with high Type 2 diabetes risk. Fifteen women participated in a randomized crossover trial where 42.5g of whole peanuts (P), peanut butter (PB), or no peanuts (control-C) were added to a 75g available carbohydrate-matched breakfast meal. Postprandial concentrations of blood glucose, insulin, non-esterified free fatty acids (NEFA), glucagon-like peptide-1 (GLP-1), peptide YY (PYY), cholecystokinin (CCK), appetitive sensations and food intake were assessed after breakfast treatments and a standard lunch (75g available carbohydrate).
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Peanut butter | Experimental | 42.5 g of Peanuts butter were added to a 75g available carbohydrate-matched breakfast meal |
|
| Whole peanut | Experimental | 42.5 g of whole peanuts were added to a 75g available carbohydrate-matched breakfast meal |
|
| No peanuts (control) | No Intervention |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Whole peanuts without skins, Peanut butter, or no peanuts (control) | Dietary Supplement | In accordance with the Food and Drug Administration qualified health claim regarding daily nut intake, 42.5 g of whole peanuts or peanut butter were added to a 75g available carbohydrate-matched breakfast meal each test session. |
| Measure | Description | Time Frame |
|---|---|---|
| Change from baseline in glucose homeostasis at eight hours | Postprandial concentrations and incremental area under the curve of blood glucose, insulin and glucagon-like peptide-1, and incremental area above the curve of non-esterified free fatty acids were assessed after breakfast treatments and a standard lunch | Baseline (-10), 15, 45, 60, 90, 120, 180, 240, 265, 295, 310, 340, 370, 430 and 490 minutes |
| Measure | Description | Time Frame |
|---|---|---|
| Change from baseline in incretin hormones at four hours | Postprandial concentrations and the incremental area under the curve of peptide YY and cholecystokinin were assessed after breakfast treatments | Baseline (-10), 15, 45, 60, 90, 120, 180 and 240 minutes |
| Change in food intake over 24 hours |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Caio EG Reis, PhD Student | University of Brasília, Brazil | Principal Investigator |
| Daniela N Ribeiro, M.Sc. | Federal University of Viçosa, Brazil | Study Chair |
| Neuza MB Costa, Ph.D. | Federal University of Espírito Santo, Brazil | Study Chair |
| Josefina Bressan, Ph.D. | Federal University of Viçosa, Brazil | Study Chair |
| Rita CG Alfenas, Ph.D. | Federal University of Viçosa, Brazil | Principal Investigator |
| Richard D Mattes, Ph.D. | Purdue University | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Federal University of Viçosa | Viçosa | Minas Gerais | 36570-000 | Brazil |
Not provided
| ID | Term |
|---|---|
| D003924 | Diabetes Mellitus, Type 2 |
| D007333 | Insulin Resistance |
| ID | Term |
|---|---|
| D003920 | Diabetes Mellitus |
| D044882 | Glucose Metabolism Disorders |
| D008659 | Metabolic Diseases |
| D009750 | Nutritional and Metabolic Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
All food consumed in laboratory and after leaving the laboratory in the experiment day were recorded |
| 24 hours |
| Change from baseline in appetitive sensations at twelve hours | Appetite ratings were scored at baseline and in a pre-determined times on a 100 mm visual analogue scale anchored with descriptors of "not at all" and "extremely" | Baseline (-10), 15, 45, 60, 90, 120, 180, 240, 265, 295, 310, 340, 370, 430, 490, 550, 610, 670 and 730 minutes |
| D004700 | Endocrine System Diseases |
| D006946 | Hyperinsulinism |